InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Immunovant, Inc.

IMVT Clue Score35
United States Fiscal year ends March CIK 0001764013 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

5
Insider
Date
Role
Action
Shares
Price
Amount
Robert Graham Susman
1 May 2026
Director
Sold on a plan
2,502
$27.17
$67.98K
Douglas J. Hughes
1 Dec 2025
Director
Sold on a plan
1,909
$23.96
$45.74K
Douglas J. Hughes
1 Dec 2025
Director
Sold on a plan
13,091
$23.14
$302.93K
Andrew J. Fromkin
1 Dec 2025
Director
Sold on a plan
2,898
$23.95
$69.41K
Andrew J. Fromkin
1 Dec 2025
Director
Sold on a plan
19,351
$23.14
$447.78K
Show all 66 transactions →

What was left out

Form 4 filings counted 53
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 10
Sales at will 47
Transactions with no price 0
Shares from compensation/vesting 2,029,785
History held since 15 May 2019